Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.77%
1,097.81
-8.55
-0.77%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.29%
612.03
+1.74
+0.29%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.76%
1,220.43
+9.21
+0.76%
—1,211.221,211.011,222.361,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.50%
1,759.52
+8.81
+0.50%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.54%
631.54
+3.37
+0.54%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.30%
857.16
+2.59
+0.30%
—854.57855.71860.09855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.67%
215.41
-1.46
-0.67%
—216.87216.87217.79215.29——
SIXT
Technology
SIXT
Technology
SIXT
+1.47%
3,614.15
+52.21
+1.47%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.55%
908.30
+4.99
+0.55%
—903.31903.26908.38901.18——
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.40
-1.14
-0.08%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.07%
2,398.37
-1.58
-0.07%
—2,399.952,404.452,418.812,396.04——
LAURUSLABS:NSE
Laurus Labs Ltd
₹1,324.30
+0.67%
(+8.80) 1D
May 15, 11:40:02 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LAURUSLABS...
Open
₹1,324.00
High
₹1,327.90
Low
₹1,309.90
Mkt. cap
714.93B
Avg. vol.
1.94M
Volume
869.08K
Dividend
0.15%
Quarterly dividend
₹0.50
Ex dividend date
May 8, 2026
P/E ratio
80.60
52-wk high
₹1,327.90
52-wk low
₹584.50
EPS
₹16.43
Shares outstanding
106.44M
No. of employees
6K
News stories
From sources across the web
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava. Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees6.17K
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com
Last report
Apr 30, 2026
Fiscal Period
Q4 2026
EPS / Est. (INR)
₹5.17 / ₹4.98
+3.85%beat
Revenue / Est. (INR)
18.23B / 19.16B
-4.81%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.70B
16.53B
17.78B
18.23B
Cost of goods sold
6.37B
6.63B
6.95B
7.00B
Cost of revenue
6.37B
6.63B
6.95B
7.00B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.15B
2.16B
2.29B
2.36B
Operating expense
6.67B
7.07B
7.24B
7.21B
Total operating expenses
13.04B
13.71B
14.19B
14.22B
Operating income
2.65B
2.83B
3.60B
4.02B
Other non operating income
104.30M
269.60M
57.60M
-
EBT including unusual items
2.25B
2.70B
3.25B
3.62B
EBT excluding unusual items
2.25B
2.70B
3.25B
3.62B
Income tax expense
631.40M
759.80M
734.50M
794.60M
Effective tax rate
28.08%
28.09%
22.58%
21.98%
Other operating expenses
3.35B
3.71B
3.74B
3.64B
Net income
1.63B
1.95B
2.52B
2.79B
Net profit margin
10.39%
11.79%
14.15%
15.31%
Earnings per share
3.02
3.61
4.65
5.17
Interest and investment income
-
-
-
-
Interest expense
-515.00M
-400.00M
-387.90M
-404.40M
Net interest expenses
-515.00M
-400.00M
-387.90M
-404.40M
Depreciation and amortization charges
1.17B
1.20B
1.21B
1.22B
EBITDA
3.68B
4.01B
4.62B
5.22B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer